Norcisapride is a chemical compound that belongs to the class of substituted benzamides and is primarily known for its role as a gastroprokinetic agent. It is a derivative of cisapride, which was used to treat gastrointestinal motility disorders. Norcisapride functions by enhancing the release of acetylcholine at the myenteric plexus, thereby increasing gastrointestinal motility. The compound is characterized by its ability to act as a serotonin receptor agonist, specifically targeting the 5-HT4 receptor, which plays a crucial role in gastrointestinal function. Norcisapride is typically administered in a pharmaceutical context, and its therapeutic effects are associated with improved gastric emptying and reduced symptoms of gastroesophageal reflux. However, like many medications, it may have side effects and contraindications, particularly concerning cardiac health, as it can influence cardiac rhythm. Due to safety concerns, the use of norcisapride has been restricted or withdrawn in several regions. Its chemical structure includes a piperidine ring and a benzamide moiety, contributing to its pharmacological properties.

Norcisapride

83863-69-8: (±)-Norcisapride, 4-amino-5-chloro-2-methoxy-N-(3-methoxypiperidin-4-yl)benzamide, Benzamide, 4-amino-5-chloro-2-methoxy-N-(3-methoxy-4-piperidinyl)-, cis-, Benzamide, 4-amino-5-chloro-2-methoxy-N-[(3R,4S)-3-methoxy-4-piperidinyl]-, rel-, Benzamide,4-amino-5-chloro-2-methoxy-N-[(3S,4R)-3-methoxy-4-piperidinyl]-, hydrochloride(1:1), Benzamide,4-amino-5-chloro-2-methoxy-N-[(3S,4R)-3-methoxy-4-piperidinyl]-,monohydrochloride, Cis-4-Amino-5-Chloro-N-(3-Methoxy-4-Piperidinyl)-2-Methoxybenzamide, R 149524, Ticalopride hydrochloride, rel-4-Amino-5-chloro-2-methoxy-N-[(3R,4S)-3-methoxy-4-piperidinyl]benzamide, cis-4-Amino-5-chloro-2-methoxy-N-(3-methoxy-4-piperidyl)benzamide

CAS 83863-69-8: Norcisapride

Cisapride Impurity 1 (Nor Cisapride)

Ref: 4Z-C-187006